Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Hydrophobic Interaction Chromatography – V 2.0

Posted on By


Biosimilars: SOP for Hydrophobic Interaction Chromatography – V 2.0


Standard Operating Procedure for Hydrophobic Interaction Chromatography in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/163/2025
Supersedes SOP/BS/163/2022
Page No. Page 1 of 10
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the standard procedure for performing Hydrophobic Interaction Chromatography (HIC) for purification and polishing of biosimilar monoclonal antibodies or recombinant proteins under GMP-compliant conditions.

2. Scope

This SOP is applicable to downstream processing where HIC is used to remove aggregates, host cell proteins (HCP), and other hydrophobic impurities during biosimilar manufacturing.

3. Responsibilities

  • Production: Setup, perform chromatography run, and document process parameters.
  • QA: Review batch records and chromatographic data for compliance.
  • Engineering: Maintain and calibrate chromatography skid and sensors.

4. Accountability

The Downstream Processing Lead is accountable for execution of HIC operations, ensuring process consistency, product integrity, and compliance with SOP.

5. Procedure

5.1 Materials and Buffer Preparation

  1. Use HIC resin (e.g., Phenyl Sepharose, Butyl Sepharose) as per process development specifications.
  2. Prepare the following buffers:
    • Equilibration Buffer: 20 mM phosphate, 1.5 M ammonium sulfate, pH 7.0
    • Elution Buffer: 20 mM phosphate, 0 M ammonium sulfate, pH 7.0
    • Cleaning Buffer: 0.5 M NaOH
    • Storage Buffer: 20% ethanol in WFI
  3. Filter buffers using 0.22 µm filters and document in Annexure-1.

5.2 Column Equilibration

  1. Install HIC column and ensure leak-free connections.
  2. Equilibrate column with 5–10 column volumes (CV) of equilibration buffer at flow rate of 100 cm/hr.
  3. Monitor UV (280 nm), conductivity, and pressure until baseline stabilizes.

5.3 Sample Preparation and Loading

  1. Adjust product feed to high salt conditions using buffer exchange or stepwise addition of ammonium sulfate.
  2. Filter the sample through a 0.22 µm filter before loading.
  3. Load the sample at flow rate of 80–120 cm/hr and monitor UV absorbance.

5.4 Washing and Elution

  1. Wash with equilibration buffer to remove unbound impurities.
  2. Elute with decreasing salt gradient or direct application of elution buffer.
  3. Collect fractions and monitor UV signal to identify product peak.
  4. Pool fractions that meet acceptance criteria for purity and concentration.

5.5 Column Cleaning and Storage

  1. Wash column with 0.5 M NaOH for 3 CV contact time.
  2. Rinse with WFI until neutral pH is achieved.
  3. Store column in 20% ethanol at 2–8°C.

5.6 Documentation

  1. Record buffer lots, chromatography parameters, fraction volumes, and chromatograms.
  2. Attach all analytical results (e.g., SDS-PAGE, SEC-HPLC) to batch record.

6. Abbreviations

  • HIC: Hydrophobic Interaction Chromatography
  • WFI: Water for Injection
  • HCP: Host Cell Protein
  • CV: Column Volume

7. Documents

  1. Buffer Preparation Record – Annexure-1
  2. Chromatography Log Sheet – Annexure-2
  3. Cleaning and Storage Log – Annexure-3

8. References

  • ICH Q8 – Pharmaceutical Development
  • WHO TRS 999 – Biologic GMP Guidelines
  • OEM Resin Manuals – Cytiva, Bio-Rad, Repligen

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Buffer Preparation Record

Buffer Name pH Salt Conc. Volume Filter ID Prepared By Date
Equilibration 7.0 1.5 M AmSO₄ 10 L FL-3124 Sunita Reddy 04/05/2025

Annexure-2: Chromatography Log Sheet

Step Flow Rate UV Pressure Start Time End Time Operator
Loading 100 cm/hr 0.85 AU 1.5 bar 11:00 11:45 Ajay Verma

Annexure-3: Cleaning and Storage Log

Date Column ID Cleaning Agent Contact Time Final pH Storage Buffer Stored At
04/05/2025 HIC-103 0.5 M NaOH 20 min 7.2 20% EtOH 2–8°C

Revision History:

Revision Date Revision No. Revision Details Reason Approved By
04/05/2025 2.0 Included SDS-PAGE and SEC analysis as standard evaluation Process harmonization
See also  Biosimilars: SOP for Risk Assessment in Genetic Engineering - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: SOP Development Workflow in a Paperless QMS Environment
Next Post: SOP for Preparing for Regulatory Inspections and Audits

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version